Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ventas, Inc. filings document the regulatory record of a healthcare real estate investment trust whose common stock trades on the New York Stock Exchange under VTR. The company’s disclosures include Form 8-K reports for operating results, quarterly and annual earnings releases, dividend-related events, material financing agreements and capital markets activity.
Recent filings also cover amendments to credit facilities, registered senior notes issued by Ventas Realty, Limited Partnership and guaranteed by Ventas, ATM sales agreement updates, officer-transition disclosures and proxy materials addressing director elections, executive compensation, shareholder voting matters and governance.
EMBLER MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Michael J. Embler received a grant of 2,047 restricted stock units of common stock, valued at $90.35 per share based on the grant-date closing price. These units vest on the earlier of one year from grant or the company’s 2027 Annual Meeting of Stockholders, bringing his direct holdings to 16,701.958 shares.
BIGMAN THEODORE reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Theodore Bigman received an equity grant of 2,047 shares of common stock in the form of restricted stock units under the Ventas, Inc. 2022 Incentive Plan. The units vest on the earlier of the one-year anniversary of the grant date or the date of the company’s 2027 Annual Meeting of Stockholders.
The grant was valued using the closing price of $90.35 per share on the grant date. After this award, Bigman directly owns 10,640 shares of Ventas common stock, reflecting routine director compensation rather than an open-market purchase or sale.
Barnes Melody C reported acquisition or exercise transactions in this Form 4 filing.
Ventas, Inc. director Melody C. Barnes reported an equity compensation grant in the form of restricted stock units tied to the company’s common stock. She received 2,047 restricted stock units, valued at the $90.35 closing price per share on the grant date. These units vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Stockholders. Following this award, Barnes directly holds a total of 35,306.958 shares of Ventas common stock.
Ventas, Inc. amended its at-the-market (ATM) Sales Agreement to make up to $3,000,000,000 aggregate gross sales price of common stock available for issuance under the program. Shares may be sold through Sales Agents on the NYSE, by negotiated transactions, or via forward sale arrangements with certain banks.
The amendment preserves multiple settlement options for any forward sale agreements (physical settlement, cash settlement or net share settlement) and notes the company may use net proceeds received upon settlement for working capital, acquisitions, investments or repayment of debt. Sales Agents and affiliated Forward Purchasers are not required to sell any specific amount; commissions will not exceed 1.5%.
Ventas, Inc. submitted a Form 13F reporting institutional holdings with a total reported market value of $79,971,809 across 1 information table entry. The report was signed by Carey S. Roberts on 05-15-2026 as the filing representative.
Ventas, Inc. Amendment No. 1 to a Schedule 13G/A shows JPMorgan Chase & beneficially owns 33,872,732 shares of Ventas common stock, representing 7.1% of the class. The filing breaks down voting and dispositive powers across JPMorgan entities, including 27,487,130 sole voting shares and 32,825,669 sole dispositive shares. The amendment is signed by a JPMorgan vice president on 05/12/2026.
Ventas, Inc. executive Peter J. Bulgarelli reported routine tax-related share dispositions linked to restricted stock unit vesting. On May 1, 2026, a total of 6,214 shares of common stock were withheld at $88.02 per share to cover taxes on RSUs granted in 2024, 2025 and 2026, in connection with his retirement effective May 1, 2026. These Form 4 entries reflect compensation and tax withholding mechanics rather than open-market buying or selling.
JPMorgan Chase & Co. reports beneficial ownership of 33,872,732 shares of Ventas, Inc. Common Stock, representing 7.1% of the class. The filing lists voting and dispositive breakdowns: sole voting power 27,487,130, shared voting power 1,383,176, sole dispositive power 32,825,669, and shared dispositive power 1,046,265. The schedule names multiple JPMorgan entities that hold the position on behalf of clients. The report is signed by a JPMorgan vice president on 05/04/2026.
Vanguard Capital Management reports beneficial ownership of 35,893,818 shares of Ventas Inc common stock, representing 7.55% of the class as reported for the period ending 03/31/2026. The filing shows sole voting power for 5,026,973 shares and sole dispositive power for 35,893,818 shares. The filing was signed on 04/30/2026 and includes a standard disclosure that ownership reflects assets managed by affiliated Vanguard business units.